Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$206.39 - $268.73 $6,191 - $8,061
-30 Reduced 0.93%
3,200 $661,000
Q1 2024

May 14, 2024

SELL
$203.52 - $273.43 $10,176 - $13,671
-50 Reduced 1.52%
3,230 $875,000
Q4 2023

Feb 06, 2024

SELL
$164.52 - $238.84 $42,775 - $62,098
-260 Reduced 7.34%
3,280 $775,000
Q3 2023

Oct 26, 2023

BUY
$194.44 - $217.61 $23,332 - $26,113
120 Added 3.51%
3,540 $693,000
Q2 2023

Aug 03, 2023

BUY
$183.71 - $210.25 $10,838 - $12,404
59 Added 1.76%
3,420 $719,000
Q1 2023

Apr 28, 2023

SELL
$191.89 - $259.92 $8,443 - $11,436
-44 Reduced 1.29%
3,361 $678,000
Q4 2022

Feb 08, 2023

SELL
$197.11 - $250.07 $15,177 - $19,255
-77 Reduced 2.21%
3,405 $741,000
Q3 2022

Oct 27, 2022

SELL
$182.44 - $250.54 $45,245 - $62,133
-248 Reduced 6.65%
3,482 $685,000
Q2 2022

Jul 29, 2022

SELL
$204.13 - $302.4 $249,242 - $369,230
-1,221 Reduced 24.66%
3,730 $798,000
Q1 2022

Apr 21, 2022

BUY
$255.51 - $362.11 $75,630 - $107,184
296 Added 6.36%
4,951 $1.41 Million
Q4 2021

Jan 28, 2022

BUY
$351.38 - $448.68 $8,784 - $11,217
25 Added 0.54%
4,655 $1.75 Million
Q2 2021

Aug 05, 2021

SELL
$294.17 - $371.65 $11,766 - $14,866
-40 Reduced 0.86%
4,630 $1.71 Million
Q1 2021

May 06, 2021

BUY
$249.67 - $299.48 $142,311 - $170,703
570 Added 13.9%
4,670 $1.35 Million
Q4 2020

Feb 08, 2021

BUY
$222.0 - $252.62 $74,370 - $84,627
335 Added 8.9%
4,100 $1.02 Million
Q3 2020

Nov 13, 2020

BUY
$175.56 - $226.45 $1,755 - $2,264
10 Added 0.27%
3,765 $853,000
Q2 2020

Aug 14, 2020

SELL
$118.84 - $189.72 $20,202 - $32,252
-170 Reduced 4.33%
3,755 $655,000
Q3 2019

Nov 13, 2019

SELL
$125.07 - $143.67 $12,507 - $14,366
-100 Reduced 2.48%
3,925 $520,000
Q2 2019

Aug 13, 2019

BUY
$123.4 - $148.55 $496,685 - $597,913
4,025 New
4,025 $571,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.45B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Simmons Bank Portfolio

Follow Simmons Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simmons Bank, based on Form 13F filings with the SEC.

News

Stay updated on Simmons Bank with notifications on news.